论文部分内容阅读
目的:探讨静脉溶栓联合介入治疗急性脑梗死的临床效果。方法:回顾性分析我院2015年1月至2017年1月期间90例急性脑梗死患者的临床资料,将入组的患者依据随机抽签原则分为对照组和研究组,每组45例,对照组患者单用静脉溶栓治疗,研究组患者在对照组的基础上联合介入治疗,比较两组患者的临床治疗效果。结果:研究组患者TIMI血流分级Ⅱ~Ⅲ级患者比率显著高于对照组(P<0.05),两组患者症状性颅内出血及术后3个月病死率之间比较无显著性差异(P>0.05),术后3个月两组患者的神经功能均显著恢复,与对照组比较,研究组恢复程度更为显著,两组比较差异性显著(P<0.05)。结论:对急性脑梗死患者联合应用静脉溶栓与介入治疗能有效改善患者的神经功能,提高闭塞血管再通率,疗效安全可靠,值得临床应用及推广。
Objective: To investigate the clinical effect of intravenous thrombolysis combined with interventional treatment of acute cerebral infarction. Methods: The clinical data of 90 patients with acute cerebral infarction from January 2015 to January 2017 in our hospital were retrospectively analyzed. The patients were divided into control group and study group according to the principle of random drawing. Each group included 45 patients, Group patients were treated with intravenous thrombolysis only. Patients in the study group were treated with interventional therapy on the basis of the control group, and the clinical effects of the two groups were compared. Results: The TIMI flow grade Ⅱ ~ Ⅲ patients in the study group were significantly higher than those in the control group (P <0.05). There was no significant difference between the two groups in the symptomatic intracranial hemorrhage and the 3-month mortality (P > 0.05). After 3 months, the neurological function of both groups recovered significantly. Compared with the control group, the recovery degree of the study group was more significant, the difference was significant (P <0.05). Conclusion: The combined application of intravenous thrombolysis and interventional therapy in patients with acute cerebral infarction can effectively improve the neurological function of patients and improve the rate of occlusion of vascular recanalization. The curative effect is safe and reliable, which is worthy of clinical application and promotion.